Further to the action taken by the Food and Drug Administration, the Ministry of Health has withdrawn from the market products containing bromfenac (Duract: Wyeth Ayerst) because of reports of liver failure, sometimes fatal.

[See also Information Exchange System Alert No. 71, 26 June 1998]

References:

1) Communication from the WHO Regional Office for the Eastern Mediterranean enclosing a notification from the Ministry of Health, Saudi Arabia, 20 June 1999.

2) FDA Talk Paper T98-36 dated 22 June 1998.